Cargando…
Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome
The ketogenic diet (KD) is a low carbohydrate and high-fat protein diet. It plays a protective role in neurodegenerative diseases by elevating the levels of ketone bodies in blood, regulating central and peripheral metabolism and mitochondrial functions, inhibiting neuroinflammation and oxidative st...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352270/ https://www.ncbi.nlm.nih.gov/pubmed/37460539 http://dx.doi.org/10.1038/s41420-023-01549-0 |
_version_ | 1785074475575803904 |
---|---|
author | Zhang, Wenlong Chen, Shiyu Huang, Xingting Tong, Huichun Niu, Hongxin Lu, Lingli |
author_facet | Zhang, Wenlong Chen, Shiyu Huang, Xingting Tong, Huichun Niu, Hongxin Lu, Lingli |
author_sort | Zhang, Wenlong |
collection | PubMed |
description | The ketogenic diet (KD) is a low carbohydrate and high-fat protein diet. It plays a protective role in neurodegenerative diseases by elevating the levels of ketone bodies in blood, regulating central and peripheral metabolism and mitochondrial functions, inhibiting neuroinflammation and oxidative stress, and altering the gut microbiota. However, studies on ketogenic therapy for Parkinson’s disease (PD) are still in their infancy. Therefore, we examined the possible protective effect of KD in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model, examined the mouse gut microbiota and its metabolites, and performed transcriptomics and metabolomics on the substantia nigra of mice. Our results showed that a long-term medium-chain triglyceride KD (MCT-KD) significantly reduced MPTP-induced damage to dopaminergic (DA) neurons, exerted antioxidant stress through the PI3K/Akt/Nrf2 pathway, and reversed oxidative stress in DA neurons. The MCT-KD also reduced mitochondrial loss, promoted ATP production, and inhibited the activation of microglia to protect DA neurons in MPTP-induced PD mice. MCT-KD altered the gut microbiota and consequently changed the metabolism of substantia nigra neurons through gut microbiota metabolites. Compared to the MPTP group, MCT-KD increased the abundance of gut microbiota, including Blautia and Romboutsia. MCT-KD also affects purine metabolism in the substantia nigra pars compacta (SNpc) by altering fecal metabolites. This study shows that MCT-KD has multiple protective effects against PD. |
format | Online Article Text |
id | pubmed-10352270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103522702023-07-19 Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome Zhang, Wenlong Chen, Shiyu Huang, Xingting Tong, Huichun Niu, Hongxin Lu, Lingli Cell Death Discov Article The ketogenic diet (KD) is a low carbohydrate and high-fat protein diet. It plays a protective role in neurodegenerative diseases by elevating the levels of ketone bodies in blood, regulating central and peripheral metabolism and mitochondrial functions, inhibiting neuroinflammation and oxidative stress, and altering the gut microbiota. However, studies on ketogenic therapy for Parkinson’s disease (PD) are still in their infancy. Therefore, we examined the possible protective effect of KD in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model, examined the mouse gut microbiota and its metabolites, and performed transcriptomics and metabolomics on the substantia nigra of mice. Our results showed that a long-term medium-chain triglyceride KD (MCT-KD) significantly reduced MPTP-induced damage to dopaminergic (DA) neurons, exerted antioxidant stress through the PI3K/Akt/Nrf2 pathway, and reversed oxidative stress in DA neurons. The MCT-KD also reduced mitochondrial loss, promoted ATP production, and inhibited the activation of microglia to protect DA neurons in MPTP-induced PD mice. MCT-KD altered the gut microbiota and consequently changed the metabolism of substantia nigra neurons through gut microbiota metabolites. Compared to the MPTP group, MCT-KD increased the abundance of gut microbiota, including Blautia and Romboutsia. MCT-KD also affects purine metabolism in the substantia nigra pars compacta (SNpc) by altering fecal metabolites. This study shows that MCT-KD has multiple protective effects against PD. Nature Publishing Group UK 2023-07-17 /pmc/articles/PMC10352270/ /pubmed/37460539 http://dx.doi.org/10.1038/s41420-023-01549-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zhang, Wenlong Chen, Shiyu Huang, Xingting Tong, Huichun Niu, Hongxin Lu, Lingli Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome |
title | Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome |
title_full | Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome |
title_fullStr | Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome |
title_full_unstemmed | Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome |
title_short | Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome |
title_sort | neuroprotective effect of a medium-chain triglyceride ketogenic diet on mptp-induced parkinson’s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352270/ https://www.ncbi.nlm.nih.gov/pubmed/37460539 http://dx.doi.org/10.1038/s41420-023-01549-0 |
work_keys_str_mv | AT zhangwenlong neuroprotectiveeffectofamediumchaintriglycerideketogenicdietonmptpinducedparkinsonsdiseasemiceacombinationoftranscriptomicsandmetabolomicsinthesubstantianigraandfecalmicrobiome AT chenshiyu neuroprotectiveeffectofamediumchaintriglycerideketogenicdietonmptpinducedparkinsonsdiseasemiceacombinationoftranscriptomicsandmetabolomicsinthesubstantianigraandfecalmicrobiome AT huangxingting neuroprotectiveeffectofamediumchaintriglycerideketogenicdietonmptpinducedparkinsonsdiseasemiceacombinationoftranscriptomicsandmetabolomicsinthesubstantianigraandfecalmicrobiome AT tonghuichun neuroprotectiveeffectofamediumchaintriglycerideketogenicdietonmptpinducedparkinsonsdiseasemiceacombinationoftranscriptomicsandmetabolomicsinthesubstantianigraandfecalmicrobiome AT niuhongxin neuroprotectiveeffectofamediumchaintriglycerideketogenicdietonmptpinducedparkinsonsdiseasemiceacombinationoftranscriptomicsandmetabolomicsinthesubstantianigraandfecalmicrobiome AT lulingli neuroprotectiveeffectofamediumchaintriglycerideketogenicdietonmptpinducedparkinsonsdiseasemiceacombinationoftranscriptomicsandmetabolomicsinthesubstantianigraandfecalmicrobiome |